Miragen, University of Colorado Collaborate on microRNA Research
October 28, 2010
Miragen, University of Colorado Collaborate on microRNA Research
Under the sponsored-research portion of the deal, Miragen will fund the analysis of miRNA and gene-expression changes from a study conducted at the University of Colorado Cardiovascular Institute at the UC Denver School of Medicine.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Miragen Preps for Series B, Expects First IND in 2011
July 15, 2010 / Gene Silencing News - Miragen Licenses miR-145 IP from University of Glasgow
March 7, 2013 / Gene Silencing News - Santaris, Miragen Expand microRNA Partnership to Include Additional Targets
January 10, 2013 / Gene Silencing News - Silence Inks Delivery Tech Evaluation Deal with Mireven
August 23, 2012 / Gene Silencing News - Regulus Inks microRNA Drugs Collaboration with AstraZeneca
August 16, 2012 / Gene Silencing News